Blockchain Short Reports

Blockchain Short Reports2020-06-26T17:12:27-04:00


Welcome to our Short Reports. Since late January 2020, all of our short reports are timestamped with blockchain technology.You can now verify to the second when a new Short Report is published and the share price at that specific point in time. The blockchain timestamps are proof of the time of publishing and content of these articles as explained below.

The companies featured on our short reports have been selected through a set of variables established by our proprietary machine learning AI and database,”Asgard”.  Asgard could thus be described as stock a selection tool that identifies high-probability fraudulent/dubious tickers and ascertains high-profitability trading entry and exit points. For more information check out our about page.

What are blockchain timestamps?

Our content is timestamped with WordProof Timestamp, which is why you might see a notification that looks like this on some of our pages:

Because of this, you (as a visitor) can verify that what we wrote and published is actually shown on the webpage: it is impossible for us (or anyone else) to tamper with the information. For each page, a fingerprint is generated (the hash), which is added to a blockchain transaction. Because of the immutability of the blockchain, this transaction (and the fingerprint) can’t be modified or removed. Thus, you know for sure (and can verify yourself) that our content was written at the indicated time.

If you are not familiar with Blockchain you can read the details here.




Anavex Life Sciences Corp. OTCQB: AVXL Short Report, 9:40am February 19, 2020

February 19th, 2020|

Intro: Like all other tickers featured in our short reports, AVXL’s has exhibited unusual behaviour recently, with its price per share more than doubling over the last three weeks. Furthermore, daily trading volume has been considerably above the 6-month daily average and RSI (14) has breached 85. Anavex has gotten itself into a fair number of headlines over recent years, so it didn’t take much digging around to find enough material for [...]

Agile Therapeutics, Inc. Nasdaq: AGRX Short Report, 9:30am February 18, 2020

February 18th, 2020|

Intro: Since early November 2019, Agile Therapeutics, Inc’s share price has seen a four-fold increase and daily trading volume has picked up significantly. We believe this to be rather suspicious, especially when considering other red flags, such as: serious dilution issues over the last year or so, a loan agreement with a “spiral of death” creditor, a loan facility with a well-known yet dubious institutional shareholder , and a CEO that has [...]

Biotricity, Inc. OTCQB: BTCY Short Report, 9:30am February 13, 2020

February 13th, 2020|

Intro: Like all other tickers featured in our short reports, BTCY’s price action has exhibited unusual behaviour recently. Over the last two months it has increased by nearly six-fold. Furthermore, its trading volume has been considerably above the 6-month daily average and RSI (14) has breached 80 on more than one occasion. It didn’t take much digging around to unearth a couple of other red flags, namely: recurrent paid promotion, dilution issues, [...]

CytoDyn, Inc. OTCQB: CYDY Short Report, February 6, 2020

February 6th, 2020|

Intro: Over the last seven weeks CYDY’s share price has a seen a near five-fold increase, daily trading volume has increased drastically and daily RSI (14) breached 80 several times. We looked into it a found some red flags that we would like to share with our readers. Flags include: obscene levels of dilution, poor financials, an underwriter with a horrific FINRA brokercheck record, a “spiral of death” creditor and highly questionable [...]

Co-Diagnostics, Inc. Nasdaq: CODX Short Report, January 28, 2020

January 28th, 2020|

Intro: Over the last three days CODX’s share price has a seen a near three-fold increase, daily trading volume has exceeded 50 million (over three times the number of outstanding shares) and daily RSI (14) has breached 90. This has been on the back of Coronavirus news pieces suggesting that CODX is preparing a test to diagnose the disease. This has also coincided with an offering pricing announcement. We looked into it [...]

Cemtrex, Inc. Nasdaq: CETX Short report, January 16, 2020

January 16th, 2020|

Intro: A quick look at CETX’s price action over the last twelve months will reveal a “bumpy” downward slope. We believe the present time is yet another “bump” in this ticker’s continued yet prolonged southward trajectory. In this short report we will be analysing some of the red flags investors and traders ought to be aware of, such as: securities class action lawsuits, worsening financials, dilution and a couple of institutional shareholders [...]